NCT04343053View on ClinicalTrials.gov

Pro-thrombotic Status in Patients with SARS-Cov-2 Infection

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

November 12, 2023

Study Completion Date

December 7, 2024

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
OTHER

SARS-Cov-2 infection

blood sample withdrawal

Trial Locations (1)

Unknown

Azienda Ospedaliera Universitaria di Ferrara, Ferrara

All Listed Sponsors
lead

University Hospital of Ferrara

OTHER

NCT04343053 - Pro-thrombotic Status in Patients with SARS-Cov-2 Infection | Biotech Hunter | Biotech Hunter